Startup entity
Every one of those 1 sits in a single category, leadership. Of the tracked stories, 1 of 1 also mention Glooko, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 6.6.
Last mentioned: Mar 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, leadership. Of the tracked stories, 1 of 1 also mention Glooko, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 6.6. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. We currently track 1 Startup story that mention MindMaze Therapeutics, all published on March 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 52 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering MindMaze Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
MindMaze Therapeutics has named healthtech veteran Zach Henderson as its new CEO, signaling a strategic shift toward aggressive global commercialization. Henderson, formerly of Glooko, succeeds founder Tej Tadi as the neurotech unicorn seeks to expand its digital rehabilitation platform across international markets.
MindMaze Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
